Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
09/2003
09/02/2003US6613880 Pipecolic acid derivatives of proline threonine amides useful for the treatment of rheumatoid arthritis
09/02/2003US6613875 Hydrophobic amino acid residue for solubilizing to a lipid membrane; self-assembly by stacking upon one another with formation of hydrogen bonds; stable disk conformation; used as drug carriers, molecular sieves, reaction vessels
09/02/2003US6613874 Melanocortin receptor ligands
09/02/2003US6613873 Covalently bound to a polyamide backbone; given formula; exhibit increased sequence specificity and binding affinity; resistant to enzyme degradation
09/02/2003US6613739 Immunosuppressants
09/02/2003US6613738 Comprising 1,2-dihydroxy-homotyrosine, 4-hydroxyproline, threonine, glutamine, 3-,4-dihydroxymethylproline, 4,5-dihydroxyornithine and lipid
09/02/2003US6613530 Determination of a specific immunoglobulin using multiple antigens
08/2003
08/28/2003WO2003071268A2 Method for discovering pharmacologically active substances
08/28/2003WO2003070967A2 Highly homogeneous molecular markers for electrophoresis
08/28/2003WO2003070755A2 Compounds, compositions and method for transporting cyclosporin molecules through the blood brain barrier
08/28/2003WO2003070751A2 Partial peptide mimetics and methods
08/28/2003WO2003070747A2 Insulin and igf-1 receptor agonists and antagonists
08/28/2003WO2003031467A3 Amino-substituted camptothecin polymer derivatives and use of the same for the manufacture of a medicament
08/28/2003WO2003031449A3 Cross-linked glycopeptide-cephalosporin antibiotics
08/28/2003WO2002097044A3 Alternative splice forms of proteins as basis for multiple therapeutic modalities
08/28/2003WO2002074783A3 Modified interferon beta with reduced immunogenicity
08/28/2003WO2002068469A3 Modified thrombopoietin with reduced immunogenicity
08/28/2003WO2002000839A3 Statement as to federally sponsored research
08/28/2003WO2001092307A3 Therapeutic compounds for ovarian cancer
08/28/2003US20030162942 Binding to ligand; adjustment of pH; elution
08/28/2003US20030162941 Graft polymer of polyester and polypeptide; prevent cyclization
08/28/2003US20030162820 Heterocyclic amides used as dipeptidyl aminopeptidase (DPIV) inhibitors, for prophylaxis of arthritis, obesity, allograft surgery, cancer, autoimmune, nervous system and skin disorders
08/28/2003US20030162718 Antigrowth agents; microbiocides, bactericides
08/28/2003US20030162717 Suppression appetite; weight loss therapy
08/28/2003US20030162697 Tripropeptin antibiotic
08/28/2003US20030162696 Modification of peptide; complexing; three-dimensional structure; hydrogen bonding
08/28/2003US20030162289 Peptides promoting cell adherence, growth and secretion
08/28/2003US20030162249 Providing a culture of bacterial cells, adding rhanmose to the culture to induce rhamnose promoter whereby the antibody heavy chain and light chain and their linked signal sequences are expressed, secreted to the periplasm
08/28/2003US20030161857 Mimetic insect allatostatin analogs for insect control
08/28/2003CA2487395A1 Method for discovering pharmacologically active substances
08/28/2003CA2477159A1 Highly homogeneous molecular markers for electrophoresis
08/28/2003CA2476427A1 Partial peptide mimetics and methods
08/28/2003CA2460055A1 Insulin and igf-1 receptor agonists and antagonists
08/28/2003CA2420355A1 Novel polypeptide and process for producing the same
08/27/2003EP1337557A2 Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension
08/27/2003EP1337551A1 Substance p analogs for the treatment of cancer
08/27/2003EP1337539A2 Linkable sialyl lewis x analogs
08/27/2003EP1337278A2 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
08/27/2003EP1157030B1 Echinocandin/carbohydrate complexes
08/27/2003EP1110086A4 Production of motif-specific and context-independent antibodies using peptide libraries as antigens
08/27/2003EP1061935A4 Proapoptotic peptides, dependence polypeptides and methods of use
08/27/2003CN1438895A Peptide composition
08/27/2003CN1438238A Type-c hepatitis virus high-variation-zone 1 synthesized peptide and use thereof
08/27/2003CN1119351C Cyclic adhesion inhibitors
08/27/2003CN1119169C Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof
08/26/2003US6610839 Promoter for telomerase reverse transcriptase
08/26/2003US6610826 Cyclopeptide derivatives with integrin inhibitor properties
08/26/2003US6610822 Purification process
08/26/2003US6610821 Cyclic peptide of given amino acid sequence; can use to improve drug delivery process, inhibit angiogenesis, increase vasopermeability; treatment of autoimmune and inflammatory diseases
08/26/2003US6610658 Modulators of μ-amyloid peptide aggregation
08/26/2003US6610657 Reducing semen migration using polypeptides which inhibit binding of protein kinases; contraceptives; antifertility agents
08/26/2003US6610655 Pentapeptide with specific conformation, its production and use
08/26/2003US6610651 Molecules that home to various selected organs or tissues
08/26/2003US6610650 Modulation of cellular transcription factor activity
08/26/2003US6610527 The taxadiene synthase gene of Pacific yew has been cloned and its nucleic acid and polypeptide sequence is presented. Truncation or removal of the transit peptide increases expression of the cloned taxadiene synthase gene expression in
08/26/2003US6610512 Zinc finger binding domains for GNN
08/26/2003US6610482 Sequencing, fingerprinting and mapping biological macromolecules, typically biological polymers. The methods make use of a plurality of sequence specific recognition reagents which can also be used for classification of
08/26/2003US6610473 Peptides for inhibiting HPV E6-proteins
08/26/2003US6610297 Compositions for treating allergies that include either BSW17 mimotope peptides or antibodies raised against BSW17 mimotope peptides. Also disclosed are methods for the treatment of allergies which involve administration of BSW17 mimeotope
08/26/2003US6610293 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
08/21/2003WO2003068956A1 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
08/21/2003WO2003068942A2 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, dna and viruses
08/21/2003WO2003068807A2 Echinocandin cyclic peptide derivatives
08/21/2003WO2003068787A1 Bi-functionalised metallocenes use for marking biological molecules
08/21/2003WO2003068201A2 High affinity antibody having a tcr-like specificity and use in detection and treatment
08/21/2003WO2003068168A2 Helical peptidomimetics and use b-amyloid-associated diseases
08/21/2003WO2003059385A3 Hiv vaccine and method of use
08/21/2003WO2003020751A3 Homing peptides
08/21/2003WO2003006070A3 Improved chelator conjugates
08/21/2003WO2002095027A3 Immunostimulatory oligodeoxynucleic molecules
08/21/2003WO2002092620A3 Peptides and related molecules that bind to tall-1
08/21/2003WO2002055554A3 Antimicrobial peptides and derived metapeptides
08/21/2003WO2002043773A3 Tissue specific prodrugs
08/21/2003WO2002020722A9 Methods and compositions for in vitro targeting
08/21/2003WO2001079479A3 Methods for selective targeting
08/21/2003WO2001060162A9 Cationic, amphipathic beta-sheet peptides and uses thereof
08/21/2003US20030158377 Forming libraries; immunosuppressant, antitumor agents
08/21/2003US20030158187 Genetic polymorphisms in the preprotachy kinin gene
08/21/2003US20030158127 Aromatic sulfenates for type I phototherapy
08/21/2003US20030158116 Peptides and compounds that bind to a receptor
08/21/2003US20030157589 Detecting bactericides/enzyme inhibitor which prevent propagtion of bacterium associated with tuberculosis and leprosy; desaturases (DES); drug screening
08/21/2003US20030157522 Modulate apoptosis; autoimmune diseases, anticancer agents
08/21/2003US20030157160 Vaccine for modulating between T1 and T2 immune responses
08/21/2003US20030157090 Redox systems; accumulation of polypeptide in plant cell; genetic engineering
08/21/2003US20030157056 Modified cytokines for use in cancer therapy
08/21/2003US20030157055 Modified cytokines for use in cancer therapy
08/21/2003CA2476292A1 Helical peptidomimetics
08/21/2003CA2475929A1 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
08/21/2003CA2474782A1 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
08/20/2003EP1335937A2 Mixed fibrils
08/20/2003EP1335743A1 Inhibition or reversal of skin aging by actin-sequestering peptides
08/20/2003EP0821003B1 Peptides and remedy for autoimmune diseases comprising the same
08/20/2003CN1437442A Peptide analogs and mimetics suitable for in vivo use in the treatment of diseases associated with abnormal protein folding into amyloid, amyloid-like deposits or beta-sheet rich pathological
08/20/2003CN1118475C Cyclopeptide derivatives
08/20/2003CN1118474C Synthetic peptides and vaccines containing the same
08/19/2003US6608173 Method for searching physiologically active substances, process for producing these substances and drugs found by the searching method
08/19/2003US6608031 Peptide comprising specified amino acid sequence
08/19/2003US6608028 Insulin-like growth factor agonist molecules
08/19/2003CA2138258C Synthetic peptides for the treatment of myasthenia gravis
08/14/2003WO2003066859A2 Amino acid sequences capable of facilitating penetration across a biological barrier
1 ... 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 ... 423